【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Overview of peptides
• Peptide synthesis
• Optimization of peptides
• Stabilization of peptides
•
PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 07: Market segmentation based on route of administration
• Parenteral
• Oral
• Pulmonary
• Mucosal
PART 08: Market segmentation by drug class
• Somatostatins
• Vasopressin
• Calcitonins
• Luteinizing hormone (LH)-releasing hormone (LHRH)
• Glucagon and analogs
• Insulins
• Other
PART 09: Market segmentation by synthesis technology
• Liquid-phase peptide synthesis
• Solid-phase peptide synthesis
• Hybrid peptide synthesis
PART 10: Geographical segmentation
• Global peptide therapeutics market segmentation by geography 2015-2020
• Peptide therapeutics market in Americas
• Peptide therapeutics market in EMEA
• Peptide therapeutics market in APAC
PART 11: Market drivers
• Increase in patient population
• Advances in peptide synthesis technology
• Promising pipeline
• Unmet medical needs
• Increase in healthcare spending
PART 12: Impact of drivers
PART 13: Market challenges
• High cost of therapy
• Adverse side effects
• Stringent regulatory compliances
• Intense market competition
PART 14: Impact of drivers and challenges
PART 15: Market trends
• Growing popularity
• Shifting focus toward untapped markets
• Contract manufacturing
• Increase in public awareness
PART 16: Vendor landscape
• Competitive scenario
• Eli Lilly
• Novo Nordisk
• Sanofi
• Takeda Pharmaceutical
• Teva Pharmaceuticals
• Other prominent vendors
PART 17: Appendix
• List of abbreviations
PART 18: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: SWOT analysis: Peptide therapeutics
Exhibit 03: Steps involved in peptide synthesis
Exhibit 04: Optimization of peptide synthesis
Exhibit 05: Methods used to stabilize peptides
Exhibit 06: Global peptide therapeutics market 2015-2020 ($ billions)
Exhibit 07: Five forces analysis
Exhibit 08: Global peptide therapeutics market segmentation based on route of administration
Exhibit 09: Global peptide therapeutics market segmentation by route of administration 2015
Exhibit 10: Global peptide therapeutics market segmentation by drug class
Exhibit 11: Global peptide therapeutics market segmentation by synthesis technology
Exhibit 12: Global peptide therapeutics market segmentation by geography 2015
Exhibit 13: Peptide therapeutics market revenue by geography 2015-2020 ($ billions)
Exhibit 14: Peptide therapeutics market in Americas 2015-2020 ($ billions)
Exhibit 15: Peptide therapeutics market in EMEA 2015-2020 ($ billions)
Exhibit 16: Peptide therapeutics market in APAC 2015-2020 ($ billions)
Exhibit 17: Global peptide therapeutics market: YoY growth and revenue based on geography 2015-2020
Exhibit 18: Impact of drivers
Exhibit 19: Impact of drivers and challenges
Exhibit 20: El Lilly: YoY growth rate and revenue of Humalog 2012-2014 ($ billions)
Exhibit 21: Eli Lilly: YoY growth rate and revenue of Cialis 2012-2014 ($ billions)
Exhibit 22: Eli Lilly: YoY growth rate and revenue of Cymbalta 2012-2014 ($ billions)
Exhibit 23: Eli Lilly: YoY growth rate and revenue of Humulin 2012-2014 ($ billions)
Exhibit 24: Eli Lilly: YoY growth rate and revenue of Forteo 2012-2014 ($ billions)
Exhibit 25: Eli Lilly: Key takeaways
Exhibit 26: Novo Nordisk: YoY growth rate and revenue of NovoLog/NovoRapid 2012-2014 ($ billions)
Exhibit 27: Novo Nordisk: Geographical split of revenues of NovoLog 2014
Exhibit 28: Novo Nordisk: YoY growth rate and revenue of NovoMix/NovoLog mix 2012-2014 ($ billions)
Exhibit 29: Novo Nordisk: Geographical split of revenues of NovoMix 2014
Exhibit 30: Novo Nordisk: YoY growth rate and revenue of Norditropin 2012-2014 ($ billions)
Exhibit 31: Novo Nordisk: Geographical split of revenues of Norditropin 2014
Exhibit 32: Novo Nordisk: YoY growth rate and revenue of Prandin 2012-2014 ($ millions)
Exhibit 33: Novo Nordisk: Geographical split of revenues of Prandin 2014
Exhibit 34: Novo Nordisk: Key takeaways
Exhibit 35: Sanofi: YoY growth rates and revenues of Lantus 2012-2014 ($ billions)
Exhibit 36: Sanofi: YoY growth rate and revenue of Amaryl 2012-2014 ($ millions)
Exhibit 37: Sanofi: YoY growth rate and revenue of Apidra 2012-2014 ($ millions)
Exhibit 38: Sanofi: YoY growth rate and of Insuman 2012-2014 ($ millions)
Exhibit 39: Sanofi: YoY revenue of Lyxumia 2013-2014 ($ millions)
Exhibit 40: Sanofi: Key takeaways
Exhibit 41: Takeda Pharmaceutical: YoY revenue of Velcade 2013-2014 ($ billions)
Exhibit 42: Takeda Pharmaceutical: YoY revenue of Leuprorelin 2013-2014 ($ billions)
Exhibit 43: Takeda Pharmaceutical: YoY revenue of Nesina 2013-2014 ($ millions)
Exhibit 44: Takeda Pharmaceutical: YoY revenue of TachoSil 2013-2014 ($ millions)
Exhibit 45: Takeda Pharmaceutical: Key takeaways
Exhibit 46: Teva Pharmaceuticals: YoY growth rate and revenue of Copaxone 2012-2014 ($ billions)
Exhibit 47: Teva Pharmaceuticals: Key takeaways
【レポート販売概要】
■ タイトル：ペプチド治療薬の世界市場：ソマトスタチン、バソプレシン、カルシトニン、LHRH、グルカゴン、インシュリン■ 英文：Global Peptide Therapeutics Market 2016-2020
■ 発行日：2016年3月4日
■ 調査会社：Technavio
■ 商品コード：IRTNTR8630
■ 調査対象地域：グローバル
- 世界のエポキシ樹脂市場動向（2012-2016）TechNavio's analysts forecast the Global Epoxy Resins market to grow at a CAGR of 7.36 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for epoxy resins in the emerging economies of Asia, Latin America, and Eastern Europe. The Global Epoxy Resins market has also been witnessing an increase in product innovation and R&D activities …
- アフェクティブコンピューティングの世界市場予測（～2021）MarketsandMarkets forecasts the affective computing market size to grow from USD 12.20 Billion in 2016 to USD 53.98 Billion by 2021, at an estimated Compound Annual Growth Rate (CAGR) of 34.7%. Major factors contributing to the growth of the market are the increasing adoption of human and machine interaction technologies. The global affective computing market is segmented by technology, software, …
- ポリウレタン接着剤の世界市場予測（～2021年）The global polyurethane (PU) adhesives market is projected to reach USD 9.38 Billion by 2021, registering a CAGR of 6.8% between 2016 and 2021. Increasing building & construction activities and growth in production of automotive are increasing the demand for PU adhesives. Emerging middle-class population in developing countries such as China, India, and Brazil have triggered the growth of the PU a …
- （製薬リーディング企業）CRO企業ベンチマークレポートPharmaLeaders: CRO Benchmark Report - Financial Performance Benchmarking & Competitive Landscape Assessment of Leading CROs Summary The CRO Benchmark Report applies GlobalData’s proprietary ranking methodology to compare the competitive positions of 11 leading CRO companies on 17 financial metrics. These companies are analyzed based on financial performance, cost-containment, capital structure and …
- 医療機器業界のM&A及び投資動向（月別）：March 2013Medical Equipment Monthly Deals Analysis: March 2013- M&A and Investment Trends Summary GlobalData's “Medical Equipment Monthly Deals Analysis: March 2013- M&A and Investment Trends” report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the medical equipment industry. The report provides detailed information on M&As, equity/debt offerings …
- Yangarra Resources Ltd.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Yangarra Resources Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Yangarra Resources Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential so …
- Wireless Emergency Services Research PackageOn June 12, 1996, the FCC essentially launched E9-1-1 with the adoption of an initial Report and Order and a Further Notice of Propose Rulemaking in this docket, establishing rules requiring wireless carriers to implement 9-1-1 and Enhanced 9-1-1 (E9-1-1) services. The FCC Order ultimately rolled out in phases that would cause wireless carriers in the United States to implement automatic location …
- 抗高脂血症薬の世界市場：薬物クラス別（スタチン、PCSK9阻害剤、胆汁酸封鎖剤、コレステロール吸収阻害剤、フィブリン酸誘導体、配合）The global antihyperlipidemic drugs market accounted for $9,456 million in 2018, and is expected to reach $16,864 million by 2026, registering a CAGR of 7.5% from 2019 to 2026. Lipids are defined as the organic compounds that are fatty acids. These fatty acids are essential and serve as building blocks of the cellular membranes in the living organisms. However, surge in level of lipids in the bloo …
- 再生可能エネルギー政策分析：July 2013Renewable Policy Analysis - July 2013 Summary The “Renewable Policy Analysis” provides in depth study of the major renewable policy developments across the globe. It gives regulatory and other associated updates for the global renewable energy market which can help the individual/company to frame their business strategies while minimizing regulatory risks. For the June 2013 issue, it covers two fe …
- 世界のセイボリースナック市場のニュース及びイベント動向（2014年7月）Synopsis The report provides a review of the latest news and key events in the global savory snacks market during July 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global savory snacks market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the g …
- ノルマルブタノールの世界市場動向及び予測N-butanol (C4H9OH) or n-butyl alcohol or normal butanol is a clear colorless flammable liquid. It is readily biodegradable with low level of toxicity. N-butanol is used as a feedstock for manufacturing various chemicals including butyl acrylate, butyl acetate, glycol ethers, and plasticizers. It is also used as direct solvent for paints, coatings, varnishes, resins, dyes, camphor, vegetable oils, …
- 世界の化粧品パッケージング市場：プラスチック、ガラス、金属、紙The cosmetic packaging market is one of the most vibrant packaging markets, which includes the diversified types of packaging and their materials used across the regions. With a huge market potential and growing consumer preference, the market is likely to witness substantial growth in the coming years. This report estimates the market value of the cosmetic packaging & its machinery. Paper, glass, …
- Apriso(潰瘍性大腸炎)：市場分析と予測（～2022）Apriso (Ulcerative Colitis) - Forecast and Market Analysis to 2022 Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely by the entry of Johnson & Johnson’s (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key event affecting …
- 炎症性疼痛(Inflammatory Pain)：世界の治験レビュー（2015年上半期版）Inflammatory Pain Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Inflammatory Pain Global Clinical Trials Review, H1, 2015" provides an overview of Inflammatory Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Inflammatory Pain. Report includes an overview of trial numbers and their average enrollment in top …
- 世界の殺菌製品及びサービス市場（医療産業）動向（2014～2018）TechNavio's analysts forecast the Global Sterilization Products and Services market to grow at a CAGR of 6.34 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing prevalence of hospital-acquired infection. The Global Sterilization Products and Services market has also been witnessing the increase in contract sterilization services. However, …
